Home › Compare › PIFMY vs ABBV
PIFMY yields 4.54% · ABBV yields 3.06%● Live data
📍 PIFMY pulled ahead of the other in Year 3
Combined, PIFMY + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PIFMY + ABBV for your $10,000?
PT Indofood Sukses Makmur Tbk operates as a food solutions company in Indonesia and internationally. It operates through four segments: Consumer Branded Products Business Group, Bogasari Business Group, Agribusiness Group, and Distribution Business Group. The company offers noodles; ultra-high temperature (UHT), sterilized bottled, evaporated, pasteurized liquid, UHT multi-cereal, and powdered milk; milk-flavored and cereal powdered drinks, sweetened condensed creamer, ice cream, and butter; potato, cassava, soybean, corn, and various extruded snacks; recipe mixes, soy and chili sauce, tomato sauce, and stock soup; baby cereals; rice puffs, crunchies, biscuits, puddings, noodle soup, and pasta; cereal snacks for children; and ready-to-drink tea, packaged water, and fruit-flavored drinks. It also produces wheat flour, pasta, and coffee; distributes consumer products; manufactures and markets cooking oils, margarine, and shortening; cultivates sugar cane, rubber, industrial timber, cocoa, coconut, tea plantations, and other crops; extracts and processes coconut oil; operates bulking station; processes oils and fat; and markets and distributes culinary products. In addition, the company engages in the research and development, seed breeding, and oil palm cultivation and milling activities; shipping, investment and management, trade export agency, industrial estate agriculture, forestry, fishing, and trading and marketing activities; ownership and management of buildings; chain restaurant management; flour milling, blending, and trading; and provision of transportation, management consulting, and research management and technical services, as well as packaging materials and fertilizers. The company was formerly known as PT Panganjaya Intikusuma and changed its name to PT Indofood Sukses Makmur Tbk in 1994. The company was incorporated in 1990 and is based in Jakarta, Indonesia. PT Indofood Sukses Makmur Tbk is a subsidiary of First Pacific Investment Management Limited.
Full PIFMY Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.